이식형 의료기기 시장 보고서 : 제품 유형별, 재료별, 최종 사용자별, 지역별(2025-2033년)

The global implantable medical devices market size reached USD 141.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 209.1 Billion by 2033, exhibiting a growth rate (CAGR) of 4.5% during 2025-2033. The rising prevalence of chronic diseases, increasing demand for smaller, more advanced implantable medical devices, and growing integration of digital health technologies and connectivity features in implantable devices are some of the key factors driving the growth of the market.

Medical implants are devices that are used to replace or act as a fraction for a particular body part or for the whole biological structure. Every year thousands of people enhance the quality of their lives by going through surgical procedures that involve the fixing or removal of implantable medical devices. At present, implants are used for various parts of the body for different functions such as orthopedics, pacemakers, cardiovascular stents, defibrillators, neural prosthetics or drug delivery system. Implants are introduced either completely or partially via surgical or medical methods into the human body. The device can be implanted permanently or temporarily, depending upon the need and can be removed later on. There has been an increase in the number of age-related diseases with concurrent rise in the life-span of people. This has further increased the demand of various life prolonging medical aids such as new treatments, implants, prostheses, and long-term pharmaceutical usage. Implantable devices are made up of various types of materials such as tissues, metals, bones, plastics, skin, ceramics, etc.

Global Implantable Medical Devices Market Trends:

Catalyzed by a strong growth of consumers' inclination towards body aesthetics and physical appearance, cosmetic surgeries are becoming increasingly common, driving the demand of implantable medical devices. Moreover, advancing technological innovations that enable an individual to enhance his/her beauty such as dental implants, pectoral implants, deltoid implants, thigh augmentation, breast implants, cochlear implants, etc. have further added to the rising demand of these devices. Additionally, rising occurrence of chronic diseases such as heart failures, arthritis, motor, sensory or cognitive modality, etc. that require various types of implants to sustain the life of a patient are also creating a positive impact on the growth of the market. Moreover, an increase in the geriatric population across both developed and developing regions has resulted in a rising prevalence of various chronic diseases which is further propelling the demand of these products.

Key Market Segmentation:

Breakup by Product Type:

Orthopedic Implants

Dental Implants

Facial Implants

Breast Implants

Cardiovascular Implants

Others

Based on the product type, the market has been segmented into orthopedic implants, dental implants, facial implants, breast implants, cardiovascular implants, and others.

Breakup by Material:

Polymers

Metals

Ceramics

Biologics

Based on the material, the market has been segmented into polymers, metals, ceramics and biologics.

Breakup by End-User:

Hospitals

Ambulatory Surgery Centers (ASCs)

Clinics

Based on the end-user, the market has been segmented into hospitals, ambulatory surgery centers and clinics.

Breakup by Region:

North America

Europe

Asia-Pacific

Middle East and Africa

Latin America

Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. North America currently represents the largest market.

Competitive Landscape:

The competitive landscape of the market has also been examined with some of the key players being Abbott Laboratories, Biotronik, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Conmed Corporation, Globus Medical, Inc., Integra Lifesciences Holdings Corporation, Johnson & Johnson, LivaNova PLC, Medtronic plc, Nuvasive, Inc., Smith & Nephew Plc, St. Jude Medical, Inc., Institut Straumann AG., Stryker Corporation, Wright Medical Group N.V. and Zimmer Biomet Holdings, Inc.

This report provides a deep insight into the global implantable medical devices market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the implantable medical devices industry in any manner.

Key Questions Answered in This Report

• 1. What was the size of the global implantable medical devices market in 2024?
• 2. What is the expected growth rate of the global implantable medical devices market during 2025-2033?
• 3. What are the key factors driving the global implantable medical devices market?
• 4. What has been the impact of COVID-19 on the global implantable medical devices market?
• 5. What is the breakup of the global implantable medical devices market based on the product type?
• 6. What is the breakup of the global implantable medical devices market based on the material?
• 7. What is the breakup of the global implantable medical devices market based on the end- user?
• 8. What are the key regions in the global implantable medical devices market?
• 9. Who are the key players/ companies in the global implantable medical devices market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Implantable Medical Devices Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Breakup by Product Type
• 5.5 Market Breakup by Material
• 5.6 Market Breakup by End-User
• 5.7 Market Breakup by Region
• 5.8 Market Forecast
• 5.9 SWOT Analysis
  • 5.9.1 Overview
  • 5.9.2 Strengths
  • 5.9.3 Weaknesses
  • 5.9.4 Opportunities
  • 5.9.5 Threats
• 5.10 Value Chain Analysis
  • 5.10.1 Overview
  • 5.10.2 Research and Development
  • 5.10.3 Raw Material Procurement
  • 5.10.4 Manufacturing
  • 5.10.5 Marketing
  • 5.10.6 Distribution
  • 5.10.7 End-Use
• 5.11 Porters Five Forces Analysis
  • 5.11.1 Overview
  • 5.11.2 Bargaining Power of Buyers
  • 5.11.3 Bargaining Power of Suppliers
  • 5.11.4 Degree of Competition
  • 5.11.5 Threat of New Entrants
  • 5.11.6 Threat of Substitutes
• 5.12 Price Analysis
  • 5.12.1 Key Price Indicators
  • 5.12.2 Price Structure
  • 5.12.3 Margin Analysis

6 Market Breakup by Product Type

• 6.1 Orthopedic Implants
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Dental Implants
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Facial Implants
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Breast Implants
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Cardiovascular Implants
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Others
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast

7 Market Breakup by Material

• 7.1 Polymers
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Metals
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Ceramics
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Biologics
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by End-User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Ambulatory Surgery Centers (ASCs)
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Clinics
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Europe
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Asia Pacific
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Middle East and Africa
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Latin America
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast

10 Manufacturing Process

• 10.1 Product Overview
• 10.2 Raw Material Requirements
• 10.3 Manufacturing Process
• 10.4 Key Success and Risk Factors

11 Competitive Landscape

• 11.1 Market Structure
• 11.2 Key Players
• 11.3 Profiles of Key Players
  • 11.3.1 Abbott Laboratories
  • 11.3.2 Biotronik
  • 11.3.3 Boston Scientific Corporation
  • 11.3.4 C. R. Bard, Inc.
  • 11.3.5 Cardinal Health, Inc.
  • 11.3.6 Conmed Corporation
  • 11.3.7 Globus Medical, Inc.
  • 11.3.8 Integra Lifesciences Holdings Corporation
  • 11.3.9 Johnson & Johnson
  • 11.3.10 LivaNova PLC
  • 11.3.11 Medtronic plc
  • 11.3.12 Nuvasive, Inc.
  • 11.3.13 Smith & Nephew Plc
  • 11.3.14 St. Jude Medical, Inc.
  • 11.3.15 Institut Straumann AG.
  • 11.3.16 Stryker Corporation
  • 11.3.17 Wright Medical Group N.V.
  • 11.3.18 Zimmer Biomet Holdings, Inc.